Accordingly, two recent reports focusing on CML stem cell metabolism confirmed this oxidative phenotype, fueled by fatty acid oxidation [80], and driven by a SIRT1/PGC1-α signaling axis [81]. Here, SIRT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.